Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications

Robyn Laube; Christian P. Selinger

doi:10.1111/apt.15686

Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications

Robyn Laube, Christian P. Selinger^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	915-916
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	51
Issue number	9
DOIs	https://doi.org/10.1111/apt.15686
Publication status	Published - 1 May 2020

Access to Document

10.1111/apt.15686

Cite this

@article{cb4233a2149343018cb5ce6cd149ca20,

title = "Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications",

author = "Robyn Laube and Selinger, {Christian P.}",

year = "2020",

month = may,

day = "1",

doi = "10.1111/apt.15686",

language = "English",

volume = "51",

pages = "915--916",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell, Wiley",

number = "9",

}

TY - JOUR

T1 - Letter

T2 - pregnant women with IBD are more likely to be adherent to biologic therapies than other medications

AU - Laube, Robyn

AU - Selinger, Christian P.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85083369957&partnerID=8YFLogxK

U2 - 10.1111/apt.15686

DO - 10.1111/apt.15686

M3 - Letter

C2 - 32285508

AN - SCOPUS:85083369957

VL - 51

SP - 915

EP - 916

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 9

ER -

Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications

Access to Document

Other files and links

Cite this